InvestorsHub Logo
Followers 80
Posts 5276
Boards Moderated 0
Alias Born 11/18/2013

Re: None

Thursday, 04/28/2022 10:14:11 AM

Thursday, April 28, 2022 10:14:11 AM

Post# of 3504
Their balance sheet looks like crap. Their most recent report indicates that they're bleeding and meanwhile making acquisitions and running trials in hopes that they'll be making some breakthroughs in their research and landing big Pharma deals. I mean this is the story of all Pharma and biotechnology companies, however.... they spent ton of money on R&D and administrative costs over the past year....